Innovative Obesity Pill Replicates Gastric Bypass Effects
A new oral medication called SYNT-101 shows early promise in mimicking gastric bypass surgery by shifting nutrient absorption to promote satiety and metabolic balance, with promising safety and metabolic effects observed in initial human trials. The drug forms a temporary coating in the duodenum, delaying glucose absorption and supporting weight loss without surgery.